ResMed's Stock Rises on Q1 Earnings and Revenue Beat, Margins Expand

ResMed Inc.’s (RMD) adjusted earnings per share (EPS) in the first quarter of fiscal 2025 were $2.20, up 34.1% year over year. The metric beat the Zacks Consensus Estimate by 8.4%.The adjustments include certain non-recurring expenses/benefits like the amortization of acquired intangibles, along with the income tax effect on those adjustments.GAAP EPS in the reported quarter was$ 2.11, up 41.6% from the year-ago level.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.Following the annou ...